Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8705 |
High Similarity |
NPD3748 |
Approved |
0.854 |
High Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8531 |
High Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8403 |
Intermediate Similarity |
NPD3750 |
Approved |
0.838 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8344 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8309 |
Intermediate Similarity |
NPD2797 |
Approved |
0.8309 |
Intermediate Similarity |
NPD3266 |
Approved |
0.8309 |
Intermediate Similarity |
NPD3267 |
Approved |
0.8273 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.8146 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8143 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8129 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.8117 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8105 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8099 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8099 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8085 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.8015 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7987 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7974 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7959 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7959 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7949 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7947 |
Intermediate Similarity |
NPD920 |
Approved |
0.7933 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7922 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7902 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7891 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7887 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7857 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7808 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.777 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7763 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7755 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7754 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.775 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7737 |
Intermediate Similarity |
NPD17 |
Approved |
0.773 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7714 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7712 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7707 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7703 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7687 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7669 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7667 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7664 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7664 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7654 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7639 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7613 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7612 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7603 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7591 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7578 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7568 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7564 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7562 |
Intermediate Similarity |
NPD919 |
Approved |
0.755 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7534 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7534 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7532 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7517 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7516 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1281 |
Approved |
0.75 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7482 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7481 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7468 |
Intermediate Similarity |
NPD37 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7467 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7467 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7467 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7467 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7465 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7448 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7447 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7447 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7438 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7438 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7438 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7432 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7415 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7413 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7405 |
Intermediate Similarity |
NPD9697 |
Approved |
0.74 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7394 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD4359 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7389 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7376 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4618 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4622 |
Approved |
0.7358 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7357 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7351 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7343 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7343 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7338 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD6652 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7329 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.732 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.732 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7312 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7312 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7293 |
Intermediate Similarity |
NPD1358 |
Approved |
0.729 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7286 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7285 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7284 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD5689 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5688 |
Approved |
0.726 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7254 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7246 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7237 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7237 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7229 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7219 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7208 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD1512 |
Approved |
0.719 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD2897 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD7427 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7135 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7114 |
Intermediate Similarity |
NPD4870 |
Approved |
0.7114 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7108 |
Intermediate Similarity |
NPD7315 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7092 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7089 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6677 |
Suspended |
0.7075 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7075
|
Intermediate Similarity |
NPD5736 |
Approved |